StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) stock

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3024% below fair value
$17.06−1.42 (-7.68%)

Close on Nov 17, 2026Market cap $1.19BP/E –Yield –

Tandem Diabetes Care enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Tandem Diabetes Care's enterprise value was $1.45B on Nov 11, 2026, against $1.41B a year earlier. Over the last 5 years it ranged from $618.33M to $8.96B, with a median of $1.70B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.45B-1.9%
2025Dec 31, 2025$1.48B-33.9%
2024Dec 31, 2024$2.24B+56.6%
2023Dec 29, 2023$1.43B-37.3%
2022Dec 30, 2022$2.28B-74.5%
2021Dec 31, 2021$8.96B+63.5%
2020Dec 31, 2020$5.48B+63.0%
2019Dec 31, 2019$3.36B+62.8%
2018Dec 31, 2018$2.06B+2616.2%
2017Dec 29, 2017$76.01M-0.6%
2016Dec 30, 2016$76.48M-74.7%
2015Dec 31, 2015$302.89M+38.6%
2014Dec 31, 2014$218.47M–
2013Dec 31, 2013-$12.32M–

More Tandem Diabetes Care figures

See a number that looks wrong?